RYAH Group Inc. (CSE: RYAH) to Deliver Solutions for Clinicians Examining Cannabis Efficacy in Cancer Treatment
Multiple ongoing studies are researching the relationship between medical cannabis and cancer treatmentThe viability of clinical studies within the sector is hampered by lack of exact measurement of a patient’s intakeRYAH Group intends to resolve this issue with the launch of it’s proprietary RYAH Smart Dry Herb InhalerThe company successfully delivered on its first Inhaler order in May 2021, and announced that they had received…